U.S. Neurovascular Catheters Market Size, Share & Trends Analysis Report By Type (Microcatheter, Balloon Catheter), By Applications (Embolic Stroke, Brain Aneurysms), By End Use (Hospitals, Clinics, Diagnostic Centers), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1 Methodology And Scope
                  1.1 Market Segmentation And Scope
                      1.1.1 Type
                      1.1.2 Application
                      1.1.3 End Use
                      1.1.4 Estimates And Forecast Timeline
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased Database:
                      1.3.2 Gvr’s Internal Database
                      1.3.3 Secondary Sources
                      1.3.4 Primary Research
                      1.3.5 Details Of Primary Research
                  1.4 Information Or Data Analysis
                      1.4.1 Data Analysis Models
                  1.5 Market Formulation & Validation
                  1.6 Model Details
                      1.6.1 Commodity Flow Analysis (Model 1)
                          1.6.1.1 Approach 1: Commodity Flow Approach
                      1.6.2 Volume Price Analysis (Model 2)
                          1.6.2.1 Approach 2: Volume Price Analysis
                  1.7 List Of Secondary Sources
                  1.8 List Of Primary Sources
                  1.9 List Of Abbreviations
                  1.10 Objectives
                      1.10.1 Objective 1
                      1.10.2 Objective 2
                      1.10.3 Objective 3
                      1.10.4 Objective 4
Chapter 2 Executive Summary
                  2.1 Market Outlook
                  2.2 Segment Outlook
                  2.3 Competitive Insights
Chapter 3 U.S. Neurovascular Catheters Market Variables, Trends & Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent Market Outlook
                      3.1.2 Ancillary Market Outlook
                  3.2 Penetration & Growth Prospect Mapping
                  3.3 Regulatory Framework
                  3.4 Market Dynamics
                      3.4.1 Market Driver Analysis
                          3.4.1.1 Rising Prevalence Of Hemorrhagic And Ischemic Stroke
                          3.4.1.2 Increasing Prevalence Of Brain Aneurysm
                          3.4.1.3 Shift Towards Minimally Invasive Neurosurgical Procedures
                          3.4.1.4 Increasing Awareness About Neurological Conditions Such As Brain Aneurysm And Stroke
                      3.4.2 Market Restraints Analysis
                          3.4.2.1 Risks Associated With The Neurovascular Catheters
                          3.4.2.2 Lack Of Infrastructure And Medical Professionals In Underdeveloped Economies To Perform Neurosurgery
                      3.4.3 Market Challenges Analysis
                          3.4.3.1 Complex Regulatory Framework And Lengthy Product Approval Process
                  3.5 Neurovascular Catheters: Market Analysis Tools
                      3.5.1 Industry Analysis - Porter’s
                      3.5.2 Swot Analysis, By Pest
                  3.6 Impact Of Covid-19 & Post Pandemic Insights
Chapter 4 U.S. Neurovascular Catheters Market: Segment Analysis, By Type, 2018 - 2030 (USD Million And Volume Unit)
                  4.1 Definition And Scope
                  4.2 Type Market Share Analysis, 2023 & 2030
                  4.3 U.S. Neurovascular Catheters Market, By Type, 2018 To 2030
                  4.4 Market Size & Forecasts And Trend Analyses, 2018 To 2030
                      4.4.1 Microcatheters
                          4.4.1.1 Microcatheters Market, 2018 - 2030 (USD Million And Volume Unit)
                      4.4.2 Balloon Catheters
                          4.4.2.1 Balloon Catheters Market, 2018 - 2030 (USD Million And Volume Unit)
                      4.4.3 Access Catheters
                          4.4.3.1 Access Catheters Market, 2018 - 2030 (USD Million And Volume Unit)
                      4.4.4 Embolization Catheters
                          4.4.4.1 Embolization Catheters Market, 2018 - 2030 (USD Million And Volume Unit)
Chapter 5 U.S. Neurovascular Catheters Market: Segment Analysis, By Applications, 2018 - 2030 (USD Million)
                  5.1 Definition And Scope
                  5.2 Applications Market Share Analysis, 2023 & 2030
                  5.3 U.S. Neurovascular Catheters Market, By Applications, 2018 To 2030
                  5.4 Market Size & Forecasts And Trend Analyses, 2018 To 2030
                      5.4.1 Embolic Stroke
                          5.4.1.1 Embolic Stroke Market, 2018 - 2030 (USD Million)
                      5.4.2 Brain Aneurysm
                          5.4.2.1 Brain Aneurysm Market, 2018 - 2030 (USD Million)
                      5.4.3 Arteriovenous Malformations
                          5.4.3.1 Arteriovenous Malformations Market, 2018 - 2030 (USD Million)
                      5.4.4 Others
                          5.4.4.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 U.S. Neurovascular Catheters Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
                  6.1 Definition And Scope
                  6.2 End Use Market Share Analysis, 2023 & 2030
                  6.3 U.S. Neurovascular Catheters Market, By End Use, 2018 To 2030
                  6.4 Market Size & Forecasts And Trend Analyses, 2018 To 2030
                      6.4.1 Hospital
                          6.4.1.1 Hospital Market, 2018 - 2030 (USD Million)
                      6.4.2 Clinics
                          6.4.2.1 Clinics Market, 2018 - 2030 (USD Million)
                      6.4.3 Ambulatory Surgical Centers
                          6.4.3.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
                      6.4.4 Others
                          6.4.4.1 Others Market, 2018 - 2030 (USD Million)
Chapter 7 U.S. Neurovascular Catheters Market - Competitive Analysis
                  7.1 Company Profiles
                      7.1.1 Medtronic
                          7.1.1.1 Company Overview
                          7.1.1.2 Financial Performance
                          7.1.1.3 Product Benchmarking
                          7.1.1.4 Strategic Initiatives
                      7.1.2 Acandis Gmbh
                          7.1.2.1 Company Overview
                          7.1.2.2 Product Benchmarking
                          7.1.2.3 Strategic Initiatives
                      7.1.3 Penumbra, Inc.
                          7.1.3.1 Company Overview
                          7.1.3.2 Financial Performance
                          7.1.3.3 Product Benchmarking
                          7.1.3.4 Strategic Initiatives
                      7.1.4 Stryker
                          7.1.4.1 Company Overview
                          7.1.4.2 Financial Performance
                          7.1.4.3 Product Benchmarking
                          7.1.4.4 Strategic Initiatives
                      7.1.5 Johnson And Johnson Services, Inc.
                          7.1.5.1 Company Overview
                          7.1.5.2 Financial Performance
                          7.1.5.3 Product Benchmarking
                          7.1.5.4 Strategic Initiatives
                      7.1.6 Microvention Inc. (Terumo Corporation)
                          7.1.6.1 Company Overview
                          7.1.6.2 Financial Performance
                          7.1.6.3 Product Benchmarking
                          7.1.6.4 Strategic Initiatives
                      7.1.7 Codman Neuro (Integra Lifesciences Corporation)
                          7.1.7.1 Company Overview
                          7.1.7.2 Financial Performance
                          7.1.7.3 Product Benchmarking
                          7.1.7.4 Strategic Initiatives
                      7.1.8 Spiegelberg Gmbh & Co. Kg
                          7.1.8.1 Company Overview
                          7.1.8.2 Product Benchmarking
                          7.1.8.3 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 U.S. neurovascular catheters market, by type, 2018 - 2030 (USD Million)
Table 4 U.S. neurovascular catheters market, by application, 2018 - 2030 (USD Billion)
Table 5 U.S. neurovascular catheters market, by end use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Neurovascular catheters market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2024)
Fig. 10 Segment Outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Neurovascular catheters market: Type movement analysis
Fig. 18 Neurovascular catheters market Type outlook: Key takeaways
Fig. 19 Microcatheters market, 2018 - 2030 (USD Million)
Fig. 20 Balloon catheters market, 2018 - 2030 (USD Million)
Fig. 21 Others market, 2018 - 2030 (USD Million)
Fig. 22 Neurovascular catheters market: Application movement analysis
Fig. 23 Neurovascular catheters market applications outlook: Key takeaways
Fig. 24 Embolic stroke market, 2018 - 2030 (USD Million)
Fig. 25 Brain aneurysm market, 2018 - 2030 (USD Million)
Fig. 26 Arteriovenous malformations market, 2018 - 2030 (USD Million)
Fig. 27 Others market, 2018 - 2030 (USD Million)
Fig. 28 Neurovascular catheters market: End use movement analysis
Fig. 29 Neurovascular catheters market end use outlook: Key takeaways
Fig. 30 Hospital market, 2018 - 2030 (USD Million)
Fig. 31 Clinics market, 2018 - 2030 (USD Million)
Fig. 32 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 U.S. outlook, 2018 & 2030
Fig. 35 U.S. market place: Key takeaways